Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

Abstract

Substantial progress in understanding mechanisms of immune regulation in allergy, asthma, autoimmune diseases, tumors, organ transplantation and chronic infections has led to a variety of targeted therapeutic approaches. Allergen-specific immunotherapy (AIT) has been used for 100 years as a desensitizing therapy for allergic diseases and represents the potentially curative and specific way of treatment. The mechanisms by which allergen-AIT has its mechanisms of action include the very early desensitization effects, modulation of T- and B-cell responses and related antibody isotypes as well as inhibition of migration of eosinophils, basophils and mast cells to tissues and release of their mediators. Regulatory T cells (Treg) have been identified as key regulators of immunological processes in peripheral tolerance to allergens. Skewing of allergen-specific effector T cells to a regulatory phenotype appears as a key event in the development of healthy immune response to allergens and successful outcome in AIT. Naturally occurring FoxP3(+) CD4(+)CD25(+) Treg cells and inducible type 1 Treg (Tr1) cells contribute to the control of allergen-specific immune responses in several major ways, which can be summarized as suppression of dendritic cells that support the generation of effector T cells; suppression of effector Th1, Th2 and Th17 cells; suppression of allergen-specific IgE, and induction of IgG4; suppression of mast cells, basophils and eosinophils and suppression of effector T cell migration to tissues. New strategies for immune intervention will likely include targeting of the molecular mechanisms of allergen tolerance and reciprocal regulation of effector and regulatory T cell subsets.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 182

1. 1.

   Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133:621-31.

   Not in our library10.1016/j.jaci.2013.12.1088

2. 2.

   Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med. 2012;18:736-49.

   Not in our library10.1038/nm.2754

3. 3.

   Akdis M, Akdis AC, Franklin Adkinson Jr BSB N, Wesley B, Busse WW, Holgate ST, Lemanske Jr RF, O’Hehir RE. Immune Tolerance. Middleton’s Allergy. 2013.

   Not in our library

4. 4.

   Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov. 2009;8:645-60.

   Not in our library10.1038/nrd2653

5. 5.

   Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol. 2006;18:718-26.

   Not in our library10.1016/j.coi.2006.09.016

6. 6.

   Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011;127:18-27.

   Not in our library10.1016/j.jaci.2010.11.030

7. 7.

   Akdis C, Papadopoulos N, Cardona V. Fighting allergies beyond symptoms: the European declaration on immunotherapy. Eur J Immunol. 2011;41:2802-4.

   Not in our library10.1002/eji.201190061

8. 8.

   Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011;127:18-27.

   Not in our library10.1016/j.jaci.2010.11.030

9. 9.

   Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:701-21.

   Not in our library10.1016/j.jaci.2010.11.050

10. 10.

    Akkoc T, Akdis M, Akdis CA. Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res. 2011;3:11-20.

    Not in our library10.4168/aair.2011.3.1.11

11. 11.

    Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011;66:596-604.

    Not in our library10.1111/j.1398-9995.2010.02534.x

12. 12.

    Deniz G, Akdis M. NK cell subsets and their role in allergy. Expert Opin Biol Ther. 2011;11:833-41.

    Not in our library10.1517/14712598.2011.572549

13. 13.

    Direskeneli H, Fujita H, Akdis CA. Regulation of TH17 and regulatory T cells in patients with Behcet disease. J Allergy Clin Immunol. 2011;128:665-6.

    Not in our library10.1016/j.jaci.2011.07.008

14. 14.

    Eiwegger T, Akdis CA. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol. 2011;41:1535-8.

    Not in our library10.1002/eji.201141668

15. 15.

    Eiwegger T, Gruber S, Geiger C, Meyer E, Dehlink E, Bannert C, et al. Impact of systemic immuno-suppression after solid organ transplantation on allergen-specific responses. Allergy. 2011;66:271-8.

    Not in our library10.1111/j.1398-9995.2010.02475.x

16. 16.

    Fujita H, Chalubinski M, Rhyner C, Indermitte P, Meyer N, Ferstl R, et al. Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol. 2011;127:1612-21.

    Not in our library10.1016/j.jaci.2011.03.039

17. 17.

    Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy. 2011;66:725-32.

    Not in our library10.1111/j.1398-9995.2011.02589.x

18. 18.

    Jutel M, Akdis CA. T-cell subset regulation in atopy. Curr Allergy Asthma Rep. 2011;11:139-45.

    Not in our library10.1007/s11882-011-0178-7

19. 19.

    Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355-60.

    Not in our library10.1016/j.jaci.2010.11.037

20. 20.

    O’Mahony L, Akdis M, Akdis CA. Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol. 2011;128:1153-62.

    Not in our library10.1016/j.jaci.2011.06.051

21. 21.

    Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Specific immunotherapy and turning off the T cell: how does it work? Ann Allergy Asthma Immunol. 2011;107:381-92.

    Not in our library10.1016/j.anai.2011.05.017

22. 22.

    Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy. 2011;41:1226-34.

    Not in our library10.1111/j.1365-2222.2011.03812.x

23. 23.

    Palomares O, O’Mahony L, Akdis CA. The many routes of dendritic cells to ensure immune regulation. J Allergy Clin Immunol. 2011;127:1541-2.

    Not in our library10.1016/j.jaci.2011.04.002

24. 24.

    Sackesen C, Birben E, Soyer OU, Sahiner UM, Yavuz TS, Civelek E, et al. The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma. Allergy. 2011;66:48-57.

    Not in our library10.1111/j.1398-9995.2010.02428.x

25. 25.

    Sin BA, Akdis M, Zumkehr J, Bezzine S, Bekpen C, Lambeau G, et al. T-cell and antibody responses to phospholipase A2 from different species show distinct cross-reactivity patterns. Allergy. 2011;66:1513-21.

    Not in our library10.1111/j.1398-9995.2011.02689.x

26. 26.

    Soyer OU, Akdis M, Akdis CA. Mechanisms of subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am. 2011;31:175-90.

    Not in our library10.1016/j.iac.2011.02.006

27. 27.

    Vale-Pereira S, Todo-Bom A, Geraldes L, Schmidt-Weber C, Akdis CA, Mota-Pinto A. FoxP3, GATA-3 and T-bet expression in elderly asthma. Clin Exp Allergy. 2011;41:490-6.

    Not in our library10.1111/j.1365-2222.2010.03640.x

28. 28.

    Vanbervliet B, Akdis M, Vocanson M, Rozières A, Benetière J, Rouzaire P, et al. Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-gamma/IL-17 balance in T cell-mediated skin inflammation. J Allergy Clin Immunol. 2011;127:943-53.

    Not in our library10.1016/j.jaci.2010.12.002

29. 29.

    Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B, et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-alpha cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol. 2011;127:200-7.

    Not in our library10.1016/j.jaci.2010.11.005

30. 30.

    Smits HH, Akdis CA. In utero priming by worms protects against respiratory allergies. J Allergy Clin Immunol. 2014;134:1280-1.

    Not in our library10.1016/j.jaci.2014.08.051

31. 31.

    Casale TB, Stokes JR. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133:612-9.

    Not in our library10.1016/j.jaci.2014.01.007

32. 32.

    Soyka MB, van de Veen W, Holzmann D, Akdis M, Akdis CA. Scientific foundations of allergen-specific immunotherapy for allergic disease. Chest. 2014;146:1347-57.

    Not in our library10.1378/chest.14-0049

33. 33.

    Jutel M, Akdis CA. Novel immunotherapy vaccine development. Curr Opin Allergy Clin Immunol. 2014;14:557-63.

    Not in our library10.1097/aci.0000000000000121

34. 34.

    Cavkaytar O, Akdis CA, Akdis M. Modulation of immune responses by immunotherapy in allergic diseases. Curr Opin Pharmacol. 2014;17:30-7.

    Not in our library10.1016/j.coph.2014.07.003

35. 35.

    Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2007;119:780-91.

    Not in our library10.1016/j.jaci.2007.01.022

36. 36.

    Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006;18:738-44.

    Not in our library10.1016/j.coi.2006.06.003

37. 37.

    Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006;6:761-71.

    Not in our library10.1038/nri1934

38. 38.

    Durham SR, Walker SM, Varga E-V, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468-75.

    Not in our library10.1056/nejm199908123410702

39. 39.

    Vickery BP, Scurlock AM, Kulis M, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014;133:468-75.

    Not in our library10.1016/j.jaci.2013.11.007

40. 40.

    Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31:1392-7.

    Not in our library10.1046/j.1365-2222.2001.01161.x

Cited by papers we hold 4

• Mast Cell Desensitization in Allergen Immunotherapy · 2022
  Not checked
• Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases · 2021
  No notice
• Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study · 2018
  Not checked
• Endotype-driven treatment in chronic upper airway diseases · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.